We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+6.77%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
-$18.3M
(-0.06%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-5.69%
Top 10 Holdings %
Top 10 Hldgs %
43.66%
Holding
291
New
10
Increased
60
Reduced
140
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$45.6M |
| 2 |
AstraZeneca
AZN
|
+$37.9M |
| 3 |
EOG Resources
EOG
|
+$23.4M |
| 4 |
UnitedHealth
UNH
|
+$20.1M |
| 5 |
Eli Lilly
LLY
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$152M |
| 2 |
Procter & Gamble
PG
|
+$129M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$128M |
| 4 |
Apple
AAPL
|
+$123M |
| 5 |
Chevron
CVX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.27% |
| 2 | Financials | 17.16% |
| 3 | Consumer Staples | 16.61% |
| 4 | Energy | 11.67% |
| 5 | Healthcare | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
SLB Ltd
SLB
$73.6B
| $3.03M | 0.01% |
61,723
+1,300
| +2% | +$62K |
|
127
CenterPoint Energy
CNP
$27.7B
| $2.96M | 0.01% |
101,676
+50,550
| +99% | +$1.49M |
|
128
Sysco
SYY
$40.8B
| $2.89M | 0.01% |
38,966
-1,739
| -4% | -$129K |
|
129
Rockwell Automation
ROK
$53.4B
| $2.65M | 0.01% |
8,052
-596
| -7% | -$172K |
|
130
Emerson Electric
EMR
$83.9B
| $2.55M | 0.01% |
28,243
-39
| -0.1% | -$3.28K |
|
131
Constellation Brands
STZ
$22.2B
| $2.39M | 0.01% |
9,720
-37,700
| -80% | -$8.82M |
|
132
CSX Corp
CSX
$93.4B
| $2.35M | 0.01% |
69,000
| – | – |
|
133
IBM
IBM
$211B
| $2.28M | 0.01% |
17,002
-1
| -0% | -$129 |
|
134
Freeport-McMoran
FCX
$90B
| $2.15M | 0.01% |
53,739
-5,330
| -9% | -$203K |
|
135
Ferrari
RACE
$69.2B
| $2.09M | 0.01% |
6,415
-4,455
| -41% | -$1.3M |
|
136
Advanced Micro Devices
AMD
$776B
| $2.08M | 0.01% |
18,252
-100
| -0.5% | -$10.4K |
|
137
Danaher
DHR
$137B
| $1.98M | 0.01% |
9,288
-301
| -3% | -$63.7K |
|
138
NVIDIA
NVDA
$4.86T
| $1.96M | 0.01% |
46,250
-60
| -0.1% | -$1.99K |
|
139
Thermo Fisher Scientific
TMO
$213B
| $1.95M | 0.01% |
3,747
+66
| +2% | +$35.6K |
|
140
Paychex
PAYX
$41.6B
| $1.95M | 0.01% |
17,427
-1,002
| -5% | -$110K |
|
141
AB InBev
BUD
$170B
| $1.94M | 0.01% |
34,222
-83,865
| -71% | -$5.07M |
|
142
Lowe's Companies
LOW
$117B
| $1.94M | 0.01% |
8,596
-228
| -3% | -$47.4K |
|
143
Regeneron Pharmaceuticals
REGN
$78.5B
| $1.92M | 0.01% |
2,675
| – | – |
|
144
Tesla
TSLA
$1.23T
| $1.92M | 0.01% |
7,331
+2,825
| +63% | +$565K |
|
145
Canadian Natural Resources
CNQ
$99.4B
| $1.78M | 0.01% |
63,268
+2,598
| +4% | +$74.2K |
|
146
Fox Class A
FOXA
$24.5B
| $1.77M | 0.01% |
52,027
-16,364
| -24% | -$535K |
|
147
United Parcel Service
UPS
$88.6B
| $1.75M | 0.01% |
9,761
+455
| +5% | +$80.8K |
|
148
Cummins
CMI
$87.5B
| $1.72M | 0.01% |
7,000
-193
| -3% | -$43.7K |
|
149
Edwards Lifesciences
EW
$49.6B
| $1.7M | 0.01% |
18,063
-705
| -4% | -$61.3K |
|
|
FISV
150
Fiserv Inc
FISV
$28.8B
| $1.7M | 0.01% |
13,444
| – | – |
|
Similar funds
HF
Fayez Sarofim & Co's Q2 2023 Portfolio in Review
As of Q2 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, down 0.06% from $28.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Fayez Sarofim & Co withdrew a net $1.63B in Q2 2023, closing 13 positions and reducing 140 holdings. Its most notable exit was AvalonBay Communities, an estimated $1.33M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Fayez Sarofim & Co opened a new position in iShares Core High Dividend ETF worth $8.67M.
- Fayez Sarofim & Co's largest Q2 2023 buy was iShares Core High Dividend ETF: 430,000 shares worth $8.67M.
- Fayez Sarofim & Co added most to CME Group in Q2 2023, an estimated $45.6M increase.
- Fayez Sarofim & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $152M.
- Fayez Sarofim & Co fully exited AvalonBay Communities in Q2 2023, selling an estimated $1.33M.
- Fayez Sarofim & Co's ten largest holdings make up 44% of its $28.6B portfolio in Q2 2023.
- Fayez Sarofim & Co opened 10 new positions and closed 13 in Q2 2023.
- Fayez Sarofim & Co's portfolio value fell 0.06% quarter-over-quarter to $28.6B.
Based on Fayez Sarofim & Co's 13F filing for Q2 2023, filed 14 Aug 2023.